Cystoid macular oedema following selective laser trabeculoplasty in a diabetic patient

Ha, Jerome; Bowling, Brad; Chen, Simon

doi:10.1111/ceo.12126

Cited by 18 publications

(10 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Cellular destruction ensues, liberating metalloproteasis and other proteolytic enzymes, which along with other factors, trigger an inflammatory response. 2 There are only 3 reported cases of CMO post-SLT in the literature 4,9,10 ; however, there are no reports of SLT causing foveal SRF. It could be postulated that anterior segment inflammation secondary to SLT resulted in posterior segment fluid accumulation due to inflammatory upregulation.…”

Section: Discussionmentioning

confidence: 99%

“…It is postulated that it induces less collateral thermal and mechanical damage than previous argon laser trabeculoplasty approaches. [2][3][4] Although an inflammatory response has been documented post-SLT, 1,5-8 the literature recognizes that cystoid macular edema (CMO) complicating SLT is a very rare occurrence, 4,9,10 reported only 3 times. However, we report a unique case of bilateral subretinal fluid (SRF) and decreased vision within 24 hours of SLT, with an acute decrease in best corrected visual acuity (BCVA) and response to conservative treatment over a 1-week period.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty

Phillis

Bourke

2016

Journal of Glaucoma

View full text Add to dashboard Cite

The sudden onset of loss of vision and the development of subfoveal SRF within 24 hours of SLT strongly suggests cause and effect. This previously unreported clinical entity of bilateral SRF within 24 hours of SLT may be secondary to an intraocular inflammatory cascade, similar to previous hypotheses regarding 3 cases of cystoid macular edema post-SLT. Given the dramatic initial loss of vision and compromised long-term visual outcome, clinicians and patients need to be informed of this new clinical entity of SLT associated with SRF and permanent retinal pigment epithelial changes.

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty

Phillis

Bourke

2016

Journal of Glaucoma

View full text Add to dashboard Cite

show abstract

“…Ein choroidales Effusionssyndrom ist in Einzelfällen ein-und sogar beidseits (biologische Theorie der Wirksamkeit) nach einseitiger SLT beschrieben worden [52,53]. Bei einigen wenigen Patienten trat kurz nach einer SLT ein zystoides Makulaödem, in einem Fall eine beidseitige foveale, subretinale Flüssigkeitsansammlung mit Visusreduktion auf [54][55][56].…”

Section: Seltene Nebenwirkungenunclassified

Stellenwert der selektiven Lasertrabekuloplastik (SLT)

Schlote¹

2017

Klin Monatsbl Augenheilkd

View full text Add to dashboard Cite

Worldwide, in recent years, selective laser trabeculoplasty (SLT) has developed into a very successful therapy for glaucoma. The article provides a review of the literature from PubMed and clinical experience. SLT is equally efficacious to argon laser trabeculoplasty (ALT) and to a first-line glaucoma medication. SLT can be used in most common forms of open-angle glaucoma and ocular hypertension. In contrast to ALT, SLT is repeatable and requires much less energy. SLT has been reported to be also successful in some rare forms of ocular hypertension/glaucoma. There is no negative influence of SLT to other forms of glaucoma treatment. Complications are rare and include intraocular pressure spikes, corneal scarring or corneal decompensation due to endothelial cell damage and cystoid macular edema. The potential of SLT as a first-line treatment of glaucoma is now under investigation. SLT is a low-risk procedure to treat glaucoma in a broad range of indications. Advantages of SLT include the potential to use SLT more and more as a primary treatment procedure. Therefore, SLT is now under intensive investigation worldwide.

show abstract

“…Case reports of patients developing hyphaema and peripheral anterior synechiae (PAS) following SLT have been published but such cases remain rare and are more common following ALT [77][78][79][80]. Cystoid macular oedema was also reported as a complication of SLT in case reports of patients with pre-existing ocular morbidities such as diabetic maculopathy, retinal vein occlusion and recent cataract surgery [81][82][83][84]. Therefore, patients with pre-disposing risk factors for macula oedema should be cautioned before SLT treatment.…”

Section: Safety Profile Of Sltmentioning

confidence: 99%

Selective laser trabeculoplasty for open angle glaucoma

Liput

Tan

2017

OphthaTherapy

View full text Add to dashboard Cite

Selective laser trabeculoplasty (SLT) is an important treatment option in open angle glaucoma. It has been shown to be as effective as argon laser trabeculoplasty in primary open angle glaucoma while having an improved safety profile. Its use is also indicated for other subtypes of open angle glaucoma (OAG) such as pseudoexfoliation (PXE) and pigmentary glaucoma. In this review, we present the current literature on the role of SLT in treating OAG. The indications, duration of effect, repeatability, cost effectiveness and clinical effectiveness of SLT were reviewed. Available evidence comparing SLT with ALT and medical treatment are also presented. We also discuss the applicability of SLT for PXE, pigmentary glaucoma, normal tension glaucoma and advanced OAG. Lastly, the complications of SLT and areas of further research are discussed.

show abstract

Cystoid macular oedema following selective laser trabeculoplasty in a diabetic patient

Cited by 18 publications

References 4 publications

Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty

Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty

Stellenwert der selektiven Lasertrabekuloplastik (SLT)

Selective laser trabeculoplasty for open angle glaucoma

Contact Info

Product

Resources

About